Across TCGA pan-cancer cohorts, FMN1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of FMN1’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where FMN1 RNA is repressed in tumor relative to normal tissue. In most cancer types FMN1 is over-expressed in tumor, although a few such as LUSC and READ show the opposite, repressed pattern.
LUSC, READ, and CHOL are the cancer types where FMN1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FMN1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.